Taltz and Postoperative wound infection - a phase IV clinical study of FDA data
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Taltz?
Taltz has active ingredients of ixekizumab. Currently, eHealthMe is studying from 26,173 Taltz users.
What is Postoperative Wound Infection?
Postoperative wound infection is found to be associated with 1,292 drugs and 649 conditions by eHealthMe. Currently, we are studying 8,805 people who have Postoperative wound infection.
Do you take Taltz and have Postoperative wound infection?Check whether Postoperative wound infection is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Taltz side effects by duration, gender and age:
- Taltz side effects (26,173 reports)
Postoperative wound infection treatments and more:
- Postoperative wound infection (8,805 reports)
All the drugs that are associated with Postoperative wound infection:
All the conditions that are associated with Postoperative wound infection:
How the study uses the data?
The study uses data from the FDA. It is based on ixekizumab (the active ingredients of Taltz) and Taltz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Oxytrol and Diazepam drug interaction - 5 seconds ago
- Onglyza and Thirst - Excessive - 7 seconds ago
- Fluconazole and Eletriptan Hydrobromide drug interaction - 8 seconds ago
- Transderm Scop and Gastroesophageal Reflux Disease - 9 seconds ago
- Excedrin and Snoring - 13 seconds ago
- Losartan and Glucose Urine Present - 17 seconds ago
- Truvada and Uveitis - 27 seconds ago
- Tazidime and Urinary Tract Infection Bacterial - 29 seconds ago
- Eliquis and Carcinoembryonic Antigen Increased - 30 seconds ago
- Carbamazepine and Limb Injury - 31 seconds ago